Clinical Trial Update: Effects of Insulin Glargine and Lixisenatide on the Brain [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effects of insulin glargine and lixisenatide on the brain in individuals with type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Lixisenatide (lixisenatide)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED